Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_assertion type Assertion NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_head.
- NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_assertion description "[Using the current tissue collection and 5-fold cross validation, the four most significant loci (CDKN2A EX2, CDX2, HOXA1 and OPCML) individually distinguish lung adenocarcinoma from non-cancer lung with a sensitivity of 67-86% and specificity of 74-82%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_provenance.
- NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_assertion evidence source_evidence_literature NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_provenance.
- NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_assertion SIO_000772 17967182 NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_provenance.
- NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_assertion wasDerivedFrom befree-20140225 NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_provenance.
- NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_assertion wasGeneratedBy ECO_0000203 NP852186.RAfA0ByvyYp95s0D0q_-DctGIg2NVxx8upNGK7oB6vcLs130_provenance.